Evidence map›Paper›PMID 36836754›Full record

ArticleLife (Basel, Switzerland)2023

Clinical-Epidemiological Characteristics and

Dalila Bernardes Leandro, Ronaldo Celerino da Silva, Jessyca Kalynne Farias Rodrigues, Maria Carollayne Gonçalves Leite, Luiz Claudio Arraes, Antonio Victor Campos Coelho, Sergio Crovella, Luisa Zupin, Rafael Lima Guimarães

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Life (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Dalila Bernardes LeandroDepartment of Genetics, Federal University of Pernambuco (UFPE), Avenida da Engenharia, S/N, Cidade Universitária, Recife 50670-901, PE, Brazil.
Ronaldo Celerino da SilvaDepartament of Virology and Experimental Therapy (LAVITE), Aggeu Magalhães Institute (IAM), Oswaldo Cruz Foundation (Fiocruz), Avenida Prof. Moraes Rego, S/N, Cidade Universitária, Recife 50670-901, PE, Brazil.
Jessyca Kalynne Farias RodriguesDepartment of Genetics, Federal University of Pernambuco (UFPE), Avenida da Engenharia, S/N, Cidade Universitária, Recife 50670-901, PE, Brazil.
Maria Carollayne Gonçalves LeiteKeizo Asami Institute (iLIKA), Federal University of Pernambuco (UFPE), Avenida Prof. Moraes Rego, S/N, Cidade Universitária, Recife 50670-901, PE, Brazil.
Luiz Claudio ArraesInstitute of Medicine Integral of Pernambuco Professor Fernando Figueira (IMIP-PE), Rua dos Coelhos, 300, Boa Vista, Recife 50070-902, PE, Brazil.
Antonio Victor Campos CoelhoHospital Israelita Albert Einstein, Av. Albert Einstein, 627/701-Morumbi, São Paulo 05652-900, SP, Brazil.ORCID 0000-0003-2143-9701
Sergio CrovellaBiological Science Program, Department of Biological and Environmental Sciences, College of Arts and Sciences, Qatar University, Doha 2713, Qatar.
Luisa ZupinInstitute for Maternal and Child Health-IRCCS "Burlo Garofolo", 34137 Trieste, Italy.ORCID 0000-0001-5886-9129
Rafael Lima GuimarãesDepartment of Genetics, Federal University of Pernambuco (UFPE), Avenida da Engenharia, S/N, Cidade Universitária, Recife 50670-901, PE, Brazil.
Universidade Federal de Pernambuco · BRFundação Oswaldo Cruz · BRHospital Israelita Albert Einstein · BRInstituto de Medicina Integral Professor Fernando Figueira · BRIRCCS Materno Infantile Burlo Garofolo · ITQatar University · QA

Funding

Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco - FACEPE APQ-0077-2.02/17 and BCT-0081-2.02/17IRCCS Burlo Garofolo /Italian Ministry of Health RC 47/20Programa Nacional de Pós-doutoramento - PNPD - Coordenação de Aperfeiçoamento de Pes-soal de Nível Superior (CAPES) grant number 88882.306352/2018-01
6 · The paper itself

Abstract

Mother-to-children transmission (MTCT) is the main infection route for HIV-1 in children, and may occur during pregnancy, delivery, and/or postpartum. It is a multifactorial phenomenon, where genetic variants play an important role. This study aims at analyzing the influence of clinical epidemiological characteristics and a variant (rs12252) in interferon-induced transmembrane protein 3 (

Indexed as

clinical epidemiological factorsHIV-1IFITM-3mother-to-children transmissionviral restriction factor

Identifiers

PMID36836754
PMCPMC9959554
OpenAlexW4318827970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.